Essex Financial Services, Inc. Cor Medix Inc. Transaction History

Essex Financial Services, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 30, 2020	SELL	$4.96 - $7.75 $49,600 - $77,500	-10,000 Closed	0 $0
Q3 2019 Nov 04, 2019	BUY	$6.38 - $9.69 $63,800 - $96,900	10,000 New	10,000 $64,000
Q2 2019 Jul 30, 2019	SELL	$5.93 - $10.57 $59,300 - $105,700	-10,000 Closed	0 $0
Q1 2019 May 02, 2019	BUY	$6.95 - $13.25 $69,500 - $132,500	10,000 New	10,000 $95,000

104

17.4M

134K

441K

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $426M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

Get notified when there are updates to the investment portfolio of Essex Financial Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Essex Financial Services, Inc. with notifications on news.